16694-17-0

Usage

Uses

Used in Pharmaceutical Research and Organic Chemistry:
4-Bromothiophene-3-carboxylic acid is used as a chemical intermediate for the synthesis of various organic compounds, particularly in the development of new drugs and materials. Its unique structure and reactivity make it a valuable component in the creation of pharmaceuticals with novel properties and therapeutic effects.
Used in Agrochemical Production:
4-Bromothiophene-3-carboxylic acid is used as a key component in the production of agrochemicals. Its chemical properties allow for the development of effective pesticides, herbicides, and other agricultural chemicals that can improve crop yields and protect plants from pests and diseases.
Used in Dye Manufacturing:
4-Bromothiophene-3-carboxylic acid is used as a raw material in the manufacturing of dyes. Its unique chemical structure contributes to the color and stability of various dyes used in different industries, such as textiles, plastics, and printing inks.

InChI:InChI=1/C5H3BrO2S/c6-3-1-4(5(7)8)9-2-3/h1-2H,(H,7,8)

Upstream product

• 3141-26-2 3,4-dibromothiophene 
• 109-72-8 n-butyllithium 
• 60-29-7 diethyl ether 
• 15719-64-9 methylammonium carbonate 
• 101079-66-7 4,5-dibromo-thiophene-3-carboxylic acid 
• 18791-78-1 4-bromothiophene-3-carboxaldehyde 
• 124-38-9 carbon dioxide 
• 78071-37-1 4-bromo-3-thiophenecarboxylic acid methyl ester 
• 7758-19-2 sodium chlorite 
• 19162-83-5 4-bromo-[3]thienyl lithium 
• 224449-33-6 4.-brorno-thiophene-3-carboxylic acid ethyl ester 
• 69363-85-5 methyl 4-aminothiophene-3-carboxylate 

Downstream Products

• 100245-61-2 4-bromothiophene-3-carboxamide 
• 16694-22-7 2,4,5-tribromothiophene-3-carboxylic acid 
• 72899-51-5 4-Bromo-thiophene-3-carbonyl chloride 
• 94-30-4 ethyl 4-methoxybenzoate 
• 100-09-4 4-methoxybenzoic acid 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 70438-00-5 4-ethoxy-thiophene-3-carboxylic acid 
• 57279-64-8 4-(2-oxo-2-phenylethyl)thiophene-3-carboxylic acid 
• 78071-37-1 4-bromo-3-thiophenecarboxylic acid methyl ester 
• 70260-05-8 (4-bromothiophen-3-yl)methanol 
• 1616923-32-0 (4-phenylthiophen-3-yl)acetonitrile 
• 334918-15-9 4-ethylthiophene-3-carboxylic acid 
• 1000369-61-8 (4-bromo-3-thienyl)(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)methanone 

Relevant academic research and scientific papers

GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula II.

GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I), as follows: wherein R1, R2, R4, W, X, Y, and G, are defined herein.

GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (III); wherein R1c, R2C, R4C, Wc, Yc, Zc and Gc, are defined herein.

PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

6,5-BICYCLIC OCTAHYDROPYRROLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to 6,5-bicyclic octahydropyrrolopyridine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

PIPERIDINE OXADIAZOLE AND THIADIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to piperidine oxadiazole and thiadiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

ETHYLDIAMINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to ethyldiamne compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

FUSED HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

Fused heteroaryl derivative compounds which are antagonists of orexin receptors are provided. The compounds can be used in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. Also provided is a composition which comprises the compound can be use to prevent or treat such diseases in which orexin receptors are involved.

AMIDOETHYL AZOLE OREXIN RECEPTOR ANTAGONISTS

An amidoethyl azole compounds are provided as antagonists of orexin receptors. The compounds may be used for treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.

PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to pyrrolidine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.